The aim of the VIZIER project is to perform ground-breaking impact on the identification of potential new drug targets against RNA viruses through comprehensive structural characterization of the replicative machinery of a carefully selected yet diverse set of viruses.
EVA is a non profit-organization that will ensure the highest standards of quality assurance, security, traceability and dissemination of viruses and derived products . see www.european-virus-archive.com
The VIZIER project ended on the 30th of April 2009.
Dengue Antiviral Research